Abstract
A lower erythrocyte deformability, which causes impairment of the microcirculation, is postulated to contribute to diabetic organ complications. Erythrocyte deformability was measured in four groups of type 1 (insulin-dependent) diabetic subjects and 30 controls by filtration and ektacytometry. Twenty-five patients without overt nephropathy and 12 with leg ulceration were studied. No decreased erythrocyte deformability was found in any of the diabetic groups with either technique, and neither did the total group of 71 diabetic subjects have a lower erythrocyte deformability when compared with the controls. In order to imitate local conditions in the kidney, erythrocyte deformability was also measured in hyperosmolar solutions. Again no differences were found between the diabetic groups separately or as a whole and the controls. Furthermore no correlation was found between erythrocyte deformability and the plasma glucose or glycosylated haemoglobin level.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Dietzel J, Affinity hypoxia as a pathogenetic factor of microangiopathy with particular reference to diabetic retinopathy. Acta Endocrinol 94 [Suppl 238]:39–52, 1980
Merimee TJ, Diabetic retinopathy: a synthesis of perspectives. N Engl J Med 322:978–983, 1990
Simpson LO, Intrinsic stiffening of red blood cells as the fundamental cause of diabetic nephropathy and microangiopathy: a new hypothesis. Nephron 39:344–351, 1985
Stuart J, Juhan Vague I, Erythrocyte rheology in diabetes mellitus. Clin Hemorheol 7:239–245, 1987
McMillan DE, Utterbach NG, La Puma J, Reduced erythrocyte deformability in diabetes. Diabetes 27:895–901, 1978
Schmidt-Schönbein H, Volger E, Red cell aggregation and red cell deformability in diabetes. Diabetes 25:897–902, 1976
Kikuchi Y, Koyama T, Oshima N, Oda K, Red blood cell deformability and venous blood pO2 in diabetics. Clin Hemorheol 8:171–181, 1988
Freyburger G, Gin H, Dousseau F, Lorient-Roudault MF, Boisseau MR, Erythrocyte membrane fluidity in diabetics: fluorescence measurement and rheological analysis. Clin Hemorheol 8:159–164, 1988
Garnier M, Attali JR, Valensi P, Delatour-Hanss E, Gaudey F, Koutsouris D, Erythrocyte deformability in diabetes and erythrocyte membrane lipid composition. Metabolism 39:794–798, 1990
Rillaerts EG, Vertommen JJ, Leeuw I de, Effect of statil (ICI 128436) on erythrocyte viscosity in vitro. Diabetes 37:471–475, 1988
Ernst E, Mattrai A, Altered red and white blood cell rheology in type II diabetes. Diabetes 35:1412–1415, 1986
Williamson JR, Gardner RA, Boylan CW, Carroll GL, Chang K, Marvel JS, Gonen B, Kilo C, Trans-Son-Tay R, Sutera SP, Microrheologic investigation of erythrocyte deformability in diabetes mellitus. Blood 65:283–288, 1985
Stone PCW, Bareford D, Keidan AJ, Jennings PE, Stuart J, Rheological study of density gradient fractionated erythrocytes in diabetes and atherosclerotic vascular disease. Clin Hemorheol 6:337–348, 1986
Adjizian JC, Pignon B, Poynard A, Ostermann G, Potron G, Clinical applications to the ektacytometer. Clin Hemorheol 4:245–254, 1984
Stuart J, Kenny MW, Aukland A, George AJ, Neumann V, Shapiro LM, Cove DH, Filtration of washed erythrocytes in atherosclerosis and diabetes mellitus. Clin Hemorheol 3:23–30, 1983
Bareford D, Jennings PE, Stone PCW, Baar S, Barnett AH, Stuart J, The effects of hyperglycaemia and sorbitol accumulation on erythrocyte deformability in diabetes mellitus. J Clin Pathol 39:722–727, 1986
Juhan Vague I, Rahmani-Jourdheuil D, Mishal Z, Roul C, Mouraye Y, Aillaud MF, Vague P, Correction by insulin added in vitro of abnormal membrane fluidity of the erythrocytes from type 1 (insulin dependent) diabetic patients. Diabetologia 29:417–420, 1986
Testa I, Rabini RA, Fumelli P, Bertoli E, Mazzanti L, Abnormal membrane fluidity and acetylcholinesterase activity in erythrocytes from insulin-dependent diabetic patients. J Clin Endocrinol Metab 67:1129–1133, 1988
Juhan I, Buonocore M, Jouve R, Vague P, Moulin JP, Vialettes B, Abnormalities of erythrocyte deformability and platelet aggregation in insulin-dependent diabetics corrected by insulin in vivo and in vitro. Lancet I:535–537, 1982
Hardeman MR, Goedhart P, Breederveld D, Laser diffraction ellipsometry of erythrocytes under controlled shear stress using a rotational viscosimeter. Clin Chim Acta 165:227–234, 1987
Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H, Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet I:1430–1432, 1982
Mogensen CE, Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 310:356–360, 1984
Yudkin JS, Forrest RD, Jackson CA, Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Lancet II:530–533, 1988
Feldt-Rasmussen B, Mathiesen ER, Deckert T, Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes. Lancet II:1300–1304, 1986
Feldt-Rasmussen B, Mathiesen ER, Jensen T, Lauritzen T, Deckert T, Effect of improved metabolic control on loss of kidney function in type 1 (insulin dependent) diabetic patients: an update of the Steno studies. Diabetologia 34:164–170, 1991
Klein R, Klein BEK, Moss SE, The incidence of gross proteinuria in people with insulin-dependent diabetes mellitus. Arch Intern Med 151:1344–1348, 1991
Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR, Publication bias in clinical research. Lancet 337:867–872, 1991
Maurin N, Influence on platelet activity and red cell fluidity of epoprostenol and two stable prostacyclin analogues in vitro. Drug Res 36:1180–1183, 1986
Dowd PM, Kovacs IB, Bland CJH, Kirby JTD, Effects of prostaglandins I2 and E1 on red cell deformability in patients with Raynaud's phenomenon and systemic sclerosis. BMJ 283:350, 1981
Slott JH, Hall K, Clark DA, Stuart MJ, Prostaglandin I2 fails to influence red cell deformability. Prostaglandins Leukot Med 8:21–22, 1982
Belch JJF, Lowe GDO, Drummond MM, Forbes CD, Prentice CRM, Prostacyclin reduces red cell deformability. Thromb Hemost 45:189, 1981
Jensen T, Bjerre-Knudsen J, Feldt-Rasmussen B, Deckert T, Features of endothelial dysfunction in early diabetic nephropathy. Lancet I:461–463, 1989
Wautier JL, Paton C, Wautier MP, Pintigny D, Abadie E, Passa P, Caen JP, Increased adhesion of erythrocytes to endothelial cells in diabetes mellitus and its relation to vascular complications. N Engl J Med 305:237–242, 1981
Caimi G, Blood viscosity and erythrocyte filterability: their evaluation in diabetes mellitus. Horm Metab Res 15:467–470, 1983
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schut, N.H., van Arkel, E.C., Hardeman, M.R. et al. No decreased erythrocyte deformability in type 1 (insulin-dependent) diabetes, either by filtration or by ektacytometry. Acta Diabetol 30, 89–92 (1993). https://doi.org/10.1007/BF00578220
Issue Date:
DOI: https://doi.org/10.1007/BF00578220